TScan Therapeutics Cash Flow Statement (2020-2025) | TCRX

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -7.17M-7.81M-7.91M-10.67M-15.84M-14.20M-16.16M-15.10M-16.25M-18.72M-22.56M-24.05M-23.00M-19.61M-30.14M-31.66M-29.89M-34.72M-34.13M-36.95M-35.71M
Depreciation and Depletion 0.35M0.40M0.47M0.66M1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M
Share-based Compensation 0.13M0.15M0.34M0.50M0.89M0.78M0.98M1.02M1.25M1.30M1.15M1.22M1.34M1.50M1.98M2.33M2.52M2.71M3.41M3.27M3.01M
Gains from Sales and Divestitures 0.18M0.23M0.32M0.12M
Gains from Investment Securities 2.49M3.09M6.45M-0.45M-0.39M-1.50M8.48M-1.28M-0.79M-0.29M
Non-cash Items 3.80M6.60M10.60M2.12M13.00M28.28M24.00M
Cash from Operations -5.79M-7.35M-9.96M-10.70M-13.64M-14.38M-20.12M-13.37M-17.00M-16.01M-23.59M-22.02M8.02M-23.77M-29.27M-26.23M-27.92M-27.41M-37.59M-33.27M-32.46M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.35M0.40M0.47M0.66M1.06M1.14M1.20M1.21M1.25M1.48M1.50M1.30M1.29M1.28M1.25M1.12M1.03M0.71M0.68M0.70M0.77M
Change in Working Capital
Change in Account Payables 0.57M0.06M0.16M1.43M0.88M-2.46M0.82M0.41M-1.12M0.41M0.49M0.37M-0.27M-0.64M-0.41M0.40M1.02M0.98M0.56M-0.43M1.93M
Change in Accured Expenses 0.57M1.18M-1.05M0.73M1.71M1.85M-2.80M0.61M1.60M1.32M0.74M0.78M1.02M1.31M-1.60M1.95M0.53M3.66M-5.41M2.67M-1.11M
Investing Activities
Capital Expenditures 1.34M1.39M2.96M3.92M0.85M2.21M0.53M1.89M0.42M1.38M0.84M0.42M1.42M0.47M0.70M0.86M1.37M0.89M1.53M1.28M1.43M
Change in Acquisitions & Divestments 45.65M15.50M56.00M75.51M76.00M76.25M34.00M
Cash from Investing Activities -1.34M-1.39M-2.96M-3.92M-0.85M-2.21M-0.53M-1.89M-0.42M-1.38M-0.84M-0.42M-61.41M1.91M36.16M-33.72M-82.35M27.29M13.53M48.44M32.58M
Financing Activities
Other financing activities 0.21M0.75M-0.96M0.23M0.09M0.12M0.07M
Change in Capital Stock
Shares Issued 0.00M0.04M0.11M0.06M89.48M0.09M0.03M0.01M0.07M-0.08M0.26M128.01M30.00M
Preferred Shares Issued 99.73M
Misc.
Cash from Financing Activities 0.00M0.04M99.63M-0.69M90.61M0.12M0.09M0.03M29.13M0.11M-0.25M0.02M0.26M161.59M1.23M45.69M-0.53M0.12M
Change in Cash -7.13M-8.70M86.71M-15.30M76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M113.23M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M
Free Cash Flow -7.13M-8.73M-12.92M-14.62M-14.49M-16.59M-20.66M-15.26M-17.43M-17.39M-24.43M-22.44M6.60M-24.23M-29.97M-27.09M-29.29M-28.30M-39.12M-34.55M-33.89M
Net Cash Flow -7.13M-8.70M86.71M-15.30M76.11M-16.47M-20.57M-15.23M11.70M-17.28M-24.43M-22.44M-53.65M-21.83M7.15M101.65M-109.04M45.57M-24.58M15.29M0.11M